Skip to main content
. 2015 Feb 10;20:119. doi: 10.11604/pamj.2015.20.119.5263

Table 1.

Rapid immunochromatographic assays and ELISA for hepatitis B Virus, hepatitis C virus and human immunodeficiency virus stratified by testing facilities

Parameter Hepatitis B Virus Hepatitis C Virus Human Immunodeficiency Virus
Elisa Negative False Positive Elisa Positive False Negative Elisa Negative False Positive Elisa Positive False Negative Elisa Negative False Positive Elisa Positive False Negative
Total 267 6(2.2) 33 1(3.0) 288 8(2.8) 12 9(75.0) 297 33 (11.1) 3 0(0.0)
Agogo 43 1(2.3) 7 0(0.0) 46 4(8.7) 4 3(75.0) 49 10 (20.4) 1 0(0.0)
Bekwai 45 2(4.4) 5 0(0.0) 46 4(8.7) 4 4(100) 50 14 (28.0) 0 0(0.0)
KATH 84 3(3.6) 16 1(6.3) 96 0(0.0) 4 2(50.0) 99 6 (6.1) 1 0(0.0)
KNUST 49 0(0.0) 1 0(0.0) 50 0(0.0) 0 0(0.0) 50 0 (0.0) 0 0(0.0)
Sunyani 46 0(0.0) 4 0(0.0) 50 0(0.0) 0 0(0.0) 49 3 (6.1) 1 0(0.0)

Data are presented as number or number (percentage). Elisa = Enzyme immunosorbent assay; KATH = Komfo Anokye Teaching Hospital; KNUST = Kwame Nkrumah University of Science and Technology